Capricor's Duchenne treatment fails to get FDA approval, shares sink
Summary
Capricor's Duchenne treatment fails to get FDA approval, shares sink Reuters
Description from Reuters.
Who is covering this
-
Capricor's Duchenne treatment fails to get FDA approval, shares sink - Reuters
Capricor's Duchenne treatment fails to get FDA approval, shares sink Reuters





Comments
Comments need JavaScript.